Literature DB >> 22964247

KPC-9, a novel carbapenemase from clinical specimens in Israel.

Carlos Hidalgo-Grass1, Gabriela Warburg, Violeta Temper, Shmuel Benenson, Allon E Moses, Colin Block, Jacob Strahilevitz.   

Abstract

A bla(KPC-9) carbapenemase variant was discovered in isolates of Klebsiella pneumoniae and Escherichia coli from a single patient. It differed from bla(KPC-3) by one amino acid substitution (Val239Ala). The K. pneumoniae isolate was typed as ST258, as was the epidemic Israeli KPC-3 clone. bla(KPC-9) was found on a plasmid indistinguishable from pKpQIL that carries bla(KPC-3) in the epidemic clone. Compared to KPC-3, KPC-9 conferred less resistance to carbapenems and higher resistance to ceftazidime.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22964247      PMCID: PMC3486598          DOI: 10.1128/AAC.01156-12

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  A carbapenem-resistant Klebsiella pneumoniae epidemic clone in Jerusalem: sequence type 512 carrying a plasmid encoding aac(6')-Ib.

Authors:  Gabriela Warburg; Carlos Hidalgo-Grass; Sally R Partridge; Marcelo E Tolmasky; Violeta Temper; Allon E Moses; Colin Block; Jacob Strahilevitz
Journal:  J Antimicrob Chemother       Date:  2012-01-26       Impact factor: 5.790

2.  Kinetics study of KPC-3, a plasmid-encoded class A carbapenem-hydrolyzing beta-lactamase.

Authors:  Jimena Alba; Yoshikazu Ishii; Kenneth Thomson; Ellen Smith Moland; Keizo Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

3.  Multiplex real-time PCR assay for detection and classification of Klebsiella pneumoniae carbapenemase gene (bla KPC) variants.

Authors:  Liang Chen; José R Mediavilla; Andrea Endimiani; Marnie E Rosenthal; Yanan Zhao; Robert A Bonomo; Barry N Kreiswirth
Journal:  J Clin Microbiol       Date:  2010-12-01       Impact factor: 5.948

4.  Recombinant proteins can be isolated from E. coli cells by repeated cycles of freezing and thawing.

Authors:  B H Johnson; M H Hecht
Journal:  Biotechnology (N Y)       Date:  1994-12

5.  Substrate selectivity and a novel role in inhibitor discrimination by residue 237 in the KPC-2 beta-lactamase.

Authors:  Krisztina M Papp-Wallace; Magdalena Taracila; John M Hornick; Andrea M Hujer; Kristine M Hujer; Anne M Distler; Andrea Endimiani; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2010-04-26       Impact factor: 5.191

6.  Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae.

Authors:  H Yigit; A M Queenan; G J Anderson; A Domenech-Sanchez; J W Biddle; C D Steward; S Alberti; K Bush; F C Tenover
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

7.  NIH Image to ImageJ: 25 years of image analysis.

Authors:  Caroline A Schneider; Wayne S Rasband; Kevin W Eliceiri
Journal:  Nat Methods       Date:  2012-07       Impact factor: 28.547

8.  Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City.

Authors:  Patricia A Bradford; Simona Bratu; Carl Urban; Melissa Visalli; Noriel Mariano; David Landman; James J Rahal; Steven Brooks; Sanda Cebular; John Quale
Journal:  Clin Infect Dis       Date:  2004-06-14       Impact factor: 9.079

9.  Phenotypic and enzymatic comparative analysis of the novel KPC variant KPC-5 and its evolutionary variants, KPC-2 and KPC-4.

Authors:  Daniel J Wolter; Philip M Kurpiel; Neil Woodford; Marie-France I Palepou; Richard V Goering; Nancy D Hanson
Journal:  Antimicrob Agents Chemother       Date:  2008-11-17       Impact factor: 5.191

10.  Crystal structure of KPC-2: insights into carbapenemase activity in class A beta-lactamases.

Authors:  Wei Ke; Christopher R Bethel; Jodi M Thomson; Robert A Bonomo; Focco van den Akker
Journal:  Biochemistry       Date:  2007-04-19       Impact factor: 3.162

View more
  13 in total

1.  Comparative genomic analysis of KPC-encoding pKpQIL-like plasmids and their distribution in New Jersey and New York Hospitals.

Authors:  Liang Chen; Kalyan D Chavda; Roberto G Melano; Michael R Jacobs; Brian Koll; Tao Hong; Albert D Rojtman; Michael H Levi; Robert A Bonomo; Barry N Kreiswirth
Journal:  Antimicrob Agents Chemother       Date:  2014-03-10       Impact factor: 5.191

Review 2.  Klebsiella pneumoniae Carbapenemase Variants Resistant to Ceftazidime-Avibactam: an Evolutionary Overview.

Authors:  Claire Amaris Hobson; Gautier Pierrat; Olivier Tenaillon; Stéphane Bonacorsi; Béatrice Bercot; Ella Jaouen; Hervé Jacquier; André Birgy
Journal:  Antimicrob Agents Chemother       Date:  2022-08-18       Impact factor: 5.938

3.  blaKPC-24-Harboring Aeromonas veronii from the Hospital Sewage Samples in China.

Authors:  Min Guo; Haizhen Yang; Chengcheng Yang; Yicheng Wen; Zhichen Zhu; Tao Wang; Jie Zhu; Liang Chen; Hong Du
Journal:  Microbiol Spectr       Date:  2022-05-12

4.  Engineering Specificity from Broad to Narrow: Design of a β-Lactamase Inhibitory Protein (BLIP) Variant That Exclusively Binds and Detects KPC β-Lactamase.

Authors:  Dar-Chone Chow; Kacie Rice; Wanzhi Huang; Robert L Atmar; Timothy Palzkill
Journal:  ACS Infect Dis       Date:  2016-10-26       Impact factor: 5.084

Review 5.  Carbapenemase-producing Klebsiella pneumoniae: molecular and genetic decoding.

Authors:  Liang Chen; Barun Mathema; Kalyan D Chavda; Frank R DeLeo; Robert A Bonomo; Barry N Kreiswirth
Journal:  Trends Microbiol       Date:  2014-10-07       Impact factor: 17.079

Review 6.  Emerging and re-emerging infectious disease in otorhinolaryngology.

Authors:  F Scasso; G Ferrari; G C DE Vincentiis; A Arosio; S Bottero; M Carretti; A Ciardo; S Cocuzza; A Colombo; B Conti; A Cordone; M DE Ciccio; E Delehaye; L Della Vecchia; I DE Macina; C Dentone; P DI Mauro; R Dorati; R Fazio; A Ferrari; G Ferrea; S Giannantonio; I Genta; M Giuliani; D Lucidi; L Maiolino; G Marini; P Marsella; D Meucci; T Modena; B Montemurri; A Odone; S Palma; M L Panatta; M Piemonte; P Pisani; S Pisani; L Prioglio; A Scorpecci; L Scotto DI Santillo; A Serra; C Signorelli; E Sitzia; M L Tropiano; M Trozzi; F M Tucci; L Vezzosi; B Viaggi
Journal:  Acta Otorhinolaryngol Ital       Date:  2018-04       Impact factor: 2.124

7.  Horizontal Transfer of Carbapenemase-Encoding Plasmids and Comparison with Hospital Epidemiology Data.

Authors:  C A Hardiman; R A Weingarten; S Conlan; P Khil; J P Dekker; A J Mathers; A E Sheppard; J A Segre; K M Frank
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

8.  Natural Variants of the KPC-2 Carbapenemase have Evolved Increased Catalytic Efficiency for Ceftazidime Hydrolysis at the Cost of Enzyme Stability.

Authors:  Shrenik C Mehta; Kacie Rice; Timothy Palzkill
Journal:  PLoS Pathog       Date:  2015-06-01       Impact factor: 6.823

Review 9.  Optimizing antimicrobial therapy in critically ill patients.

Authors:  Virginie Vitrat; Serge Hautefeuille; Cécile Janssen; David Bougon; Michel Sirodot; Leonardo Pagani
Journal:  Infect Drug Resist       Date:  2014-10-20       Impact factor: 4.003

Review 10.  Epidemiology of carbapenemase-producing Enterobacteriaceae and Acinetobacter baumannii in Mediterranean countries.

Authors:  Nassima Djahmi; Catherine Dunyach-Remy; Alix Pantel; Mazouz Dekhil; Albert Sotto; Jean-Philippe Lavigne
Journal:  Biomed Res Int       Date:  2014-05-13       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.